Indonesia Healthcare Market Outlook to 2022 - by Hospitals, Clinical Laboratories, Pharmaceutical, Pharmacy Chains, Medical Device Segment

Indonesia Healthcare Market Outlook to 2022 - by Hospitals, Clinical Laboratories, Pharmaceutical, Pharmacy Chains, Medical Device Segment


  • Products Id :- KR586
  • |
  • Pages: 362
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

The report titled "Indonesia Healthcare Market Outlook to 2022 - by Hospitals, Clinical Laboratories, Pharmaceutical, Pharmacy Chains, Medical Device Segment" provides information on market size for Indonesia Healthcare, hospital, pharmaceutical, pharmacy retail, clinical laboratory and medical devices. The report covers aspects such as healthcare market segment (by hospitals, pharmaceuticals, medical devices and clinical laboratory), hospital market segment (by public & private hospitals, by general & specialty hospitals and by region), pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), pharmacy retail market segment (by pharmacies & drugstores and by region), clinical laboratory market segment (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region) and medical device market segment (by type of medical device, by type of medical consumables, by end user and by procurement), competitive landscape of major Hospitals (Mitra Keluarga Karyasehat Tbk Pt, Siloam Hospitals, PT Sejahteraraya Anugrahjaya, Sarana Meditama, Rumah Sakit Pondok Indah, Surya Husadha, Jakarta Eye Center), pharmaceutical companies (PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific, PT Merck), Pharmacy Retail (Guardian Pharmacy, Kimia Farma, Apotek K-24, A S Watsons, Century Healthcare), Diagnostic Laboratories (Prodia, Kimia Farma Diagnostika, Pramita, Cito, BioMedika, Parahita), Medical Devices Companies (GE Healthcare Indonesia, Siemens Indonesia, Philips Indonesia, PT Mensa Binasukses, PT Transmedic Indonesia). The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Indonesia Healthcare Market

Indonesia Healthcare Market Overview
Indonesia Healthcare market revenue has increased from USD ~ billion in 2012 to USD ~ billion in 2017. The healthcare market has increased on the account of increasing healthcare facilities, innovation in pharmaceutical manufacturers and clinical laboratory services and expansion of pharmacy retail chains across the country.

Market Segmentation

Indonesia Hospital Market
Indonesia Hospital Market grew from USD ~ million in the year 2012 to USD ~ million in the year 2017. Public hospitals have accounted for ~% of the number of hospitals on account of the increase in the government budget allocation on healthcare. Private hospitals have registered ~% of the total hospitals in Indonesia in 2016 as the demand for modern medicine and specialist services increased in the country.

By General and Specialty Hospitals: General hospitals have accounted for ~% of the total number of hospitals whereas specialty hospitals which include hospitals such as mental hospital, leprosy hospital, eye hospital and others have registered ~% of the total number of hospitals.

Indonesia Pharmaceutical Market
Indonesia Pharmaceutical market has registered an increase in the revenue at a CAGR of ~% from USD ~ billion in 2012 to USD ~ billion in 2017.

By Therapeutic Segment: Anti-infective drug sale has contributed to the largest share of ~% in the revenue share of Indonesia Pharmaceutical industry in 2017. This is followed by Gastrointestinal and metabolism drugs with ~%, cardiovascular system drugs with ~%, Central Nervous system drugs with ~%, Respiratory system drugs with ~%, Musculoskeletal system drugs with ~%, dermatology drugs with ~%, genitourinary and hormonal drugs with ~%, blood related drugs with ~%, oncology with ~% and rest of the therapeutic segments with ~% of the revenue share in 2017.

By Domestic and International Players: Domestic players have accounted for ~% of the revenue in Indonesia pharmaceutical market in 2017 driven by the implementation of JKN (National Health Insurance System) in 2014. International players have captured ~% of the revenue share in 2017 driven by favorable government norms for foreign ownership.

By Generic and Patented Drug: Generic drugs have accounted for the major revenue share of ~% in 2017 driven by the increased demand from government run hospitals and clinics. The share of patented drugs has increased from ~% in 2013 to ~% in 2017. Further, ethical generic drugs have accounted for ~% of Indonesia generic drug market revenue in 2017 followed by free sale drugs with ~% and unbranded drug sale with ~%.

Indonesia Pharmacy Retail Market
Indonesia pharmacy retail market revenue has escalated from USD ~ billion in 2012 to USD ~ billion in 2017 at a CAGR of ~%.

By Pharmacies and Drugstores: Pharmacies have registered ~% of the revenue share in Indonesia pharmacy retail market 2017 driven by higher margins and wider portfolio of pharmacies. The drugstores which are licensed to sell only medicinal drugs have accounted for ~% in 2017

By Region: West Java has accounted for ~% of the total number of pharmacies and drugstores located in Indonesia in 2015 driven by high population in the region and presence of generic drug manufacturers. This is followed by East Java with ~%, Central Java with ~%, Jakarta with ~% and North Sumatra with ~% of the pharmacies and drugstores in Indonesia in 2015. Rest of Indonesia has accounted for ~% of the drugstores.

Indonesia Clinical Laboratory Market
Indonesia clinical laboratory market increased from USD ~ million in 2012 to USD ~ million in 2017 at a CAGR of ~%.

By Type of Laboratory: The public clinical labs have accounted for ~% of the revenue share in Indonesia clinical laboratory market in 2017. Private hospital labs have accounted for ~% in 2017 and private independent labs with ~% of the overall market.

By Type of Private Independent Laboratory: The laboratory chains such as Prodia, Kimia Farma Diagnostik, Pramita, Cito, BioMedika and Parahita have together accounted for ~% of revenue the overall private independent laboratory market in 2016. Single independent labs have contributed to their lower revenue share of ~% due to their restricted geographic presence.

By Type of Tests in Private Independent Laboratory: Routine tests have accounted for ~% of the revenue in Indonesia Private independent laboratory market in 2016. This is followed by esoteric tests with ~% and non laboratory tests with ~% of the overall private independent laboratory market.

Indonesia Medical Device Market
Indonesia Medical device revenue increased from USD ~ billion in 2012 to USD ~ billion in 2017 at a CAGR of ~%

By Type of Medical Device: Diagnostic imaging products have accounted for the largest share of ~% of the revenue share in Indonesia Medical Devices market in 2017. This is followed by medical consumable product with ~%, aesthetic devices with ~%, auxiliary devices with ~%, dental products with ~% and orthopedic implants with ~%. Others which include Point of Care Testing devices, radiation oncology devices, therapy system and testing and measurement systems have accounted for ~% of the overall market revenue.

By Procurement: Imports have accounted for ~% of the revenue share in Indonesia Medical Device Market in 2017. The imports are largely related to more sophisticated medical and surgical instruments and infrastructure. The share of local companies in the market revenue has increased from ~% in 2014 to ~% in 2017.

Snapshot on Indonesia Polyclinic Market
Demand for various healthcare services in the country has escalated over the past five years owing to increased prevalence of various life-style related diseases such as Diabetes, Obesity, Hypertension, Blood Pressure, Cardio vascular diseases and expanding population base of the country over the last five years has cemented the polyclinic market’s position as a major healthcare service provider in the country. Majority of people in Indonesia have preferred polyclinics over hospitals in the past few years due to convenience and lower cost of healthcare services. The number of Puskesmas in Indonesia has increased from ~ in 2012 to ~ in 2016.

Key Topics Covered in the Report:

  • Indonesia Healthcare, Hospitals, Pharmaceutical, Pharmacy Retail, Clinical Laboratory, Medical Devices Market Size, 2012-2017
  • Indonesia Hospitals Market Segmentation (by public & private hospitals, by general & specialty hospitals and by region)
  • Indonesia Hospitals, Pharmaceutical, Pharmacy Retail, Clinical Laboratory, Medical Devices Market Competitive Landscape
  • Indonesia Hospital, Pharmaceutical, Pharmacy Retail, Clinical Laboratory, Medical Devices Future Outlook and Projections, 2018-2022
  • Indonesia Pharmaceuticals Market Segmentation (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region)
  • Indonesia Pharmacy Retail Market Segmentation (by pharmacies & drugstores and by region)
  • Indonesia Clinical Laboratory Market Segmentation (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region)
  • Indonesia Medical Devices Market Segmentation (by type of medical device, by type of medical consumables, by end user and by procurement)
  • Analyst Recommendations
  • Macro-economic Factors Impacting Indonesia Healthcare Market


Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1. Executive Summary
Indonesia Healthcare Market Overview
Market Segmentation
Indonesia Hospital Market
Indonesia Pharmaceutical Market
Indonesia Pharmacy Retail Market
Indonesia Clinical Laboratory Market
Indonesia Medical Device Market
Snapshot on indonesia Polyclinic market
2. Research Methodology
2.1. Market Definitions
2.2. Abbreviations
2.3. Market Size and Modeling
Consolidated Research Approach
Market Sizing - Medical Devices Market
Market Sizing - Hospitals Market
Market Sizing - Clinical Laboratories Market
Market Sizing - Pharmaceutical Market
Market Sizing - Pharmacy Retail Market
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
3. Indonesia Healthcare Market, 2012-2017
3.1. Indonesia Healthcare Statistics
3.2. Universal Health Coverage and Health Care Financing Indonesia
3.3. Indonesia Healthcare Insurance
3.4. Indonesia Healthcare Value Chain
3.5. SWOT Analysis for Indonesia Healthcare Market
3.6. Indonesia Healthcare Market Size, 2012-2017
3.7. Indonesia Healthcare Segmentation
3.7.1. By Hospitals, Pharmaceuticals, Medical Devices and Clinical Laboratory, 2012-2017
4. Indonesia Hospital Market Overview and Genesis
4.1. Indonesia Hospital Market Size, 2012-2017
4.2. Indonesia Hospital Market Segmentation
4.2.1. By Public and Private Hospitals, 2012-2016
4.2.2. By General and Specialty Hospitals, 2012-2016
By Type of Specialty Hospitals on the Basis of Number of Hospitals and Beds, 2012-2015
4.2.3. By Region, 2016
4.3. Business Model for Indonesia Hospital Market
4.4. Trends and Developments in Indonesia Hospital Market
Rising Foreign Investment
Implementation of Universal Health Coverage Programme
Increasing Prevalence of Chronic Diseases
Increase in Hospitals and Clinics
Rising number of Private Hospitals
Rising Adoption of Technology Enabled Healthcare Services in Indonesia
4.5. Issues and Challenges
Lack of Qualified Doctors and Nurses
Low Bed to Population Ratio
4.6. Government Initiatives, Rules and Regulation In Indonesia Hospital Market
4.7. Major Hospital Projects in Indonesia Hospital Market
4.8. Competitive Landscape of Major Hospital Chains in Indonesia Hospital Market
4.9. Company Profiles
4.9.1. Mitra Keluarga Karyasehat Tbk PT
4.9.2. Siloam Hospitals
Case Study on Siloam Hospitals Located in Purwakarta, Java
Demand Analysis for Siloam Hospitals Located in Purwakarta, Java
4.9.3. PT Sejahteraraya Anugrahjaya
4.9.4. Sarana Meditama
4.9.5. Rumah Sakit Pondok Indah
4.9.6. Surya Husadha General Hospital
4.9.7. Jakarta Eye Center
4.9.8. Other Company Profiles
4.10. Indonesia Hospitals Future Outlook and Projections by Revenue, 2018-2022
4.11. Analyst Recommendations
5. Indonesia Pharmaceutical Market Introduction
5.1. Indonesia Pharmaceutical Market Size, 2012-2017
5.2. Indonesia Pharmaceutical Market Segmentation, 2017
5.2.1. By Therapeutic Segments (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2015 & 2017
Vitamins and Dietary Supplements Market, 2012-2017
5.2.2. By Domestic and International Players, 2012-2017
5.2.3. By Generic and Patented Drug, 2017
By Type of Generic Drugs (Unbranded, Ethical and Free Sales), 2013 and 2017
5.2.4. By OTC and Prescription Drugs, 2012-2017
5.2.5. By Domestic Sales and Exports, 2012-2016
5.2.6. By Region (West Java, East Java, Central Java, Jakarta and Others), Dec 2016
5.3. Trends, Developments and Restraint in Indonesia Pharmaceutical Market
Growth in Indonesia Animal Pharmaceutical and Vaccine Market
Increased Government Support
Rise in Mergers and Acquisitions Activities
Growing Investment from Foreign Companies
Dependence on Imports for API (Active Pharmaceutical ingredient) Procurement
Other Challenges Faced
5.4. Government Regulations for Indonesia Pharmaceutical market
Pharmaceutical Finished Products Registration Requirement
Registration Procedure
Pharmaceutical Raw Materials
Advertising and Distribution
FDI in Pharmaceutical Industry
Procedure of Applying for Patent in Indonesia
Import Regulations
Draft Law on Monitoring of Pharmaceutical Supply, Medical Devices and Household Health Products
Draft law on Hala Product Guarantee
Regulations for Non-Indonesian Stakeholders Planning to Enter the Pharmaceutical Market
5.5. Indonesia Biopharmaceutical Industry Snapshot
Innogene Kalbiotech
5.6. Snapshot on Indonesia Vaccine Market
5.7. Competitive Scenario for Major Players in Indonesia Pharmaceutical Market
5.8. Market Share of Major Players in Indonesia Pharmaceutical Market, 2015
5.9. Competitive Landscape of Major Players in Indonesia Pharmaceutical Market
5.9.1. PT Kalbe Farma
Product Portfolio for PT Kalbe Farma
5.9.2. PT Sanbe Farma
Product Portfolio for PT Sanbe Farma
5.9.3. PT SOHO Global Health
5.9.4. PT Dexa Medica
Product Portfolio for Dexa Medica
5.9.5. PT Pharos
Product Portfolio for PT Pharos
5.9.6. PT Kimia Farma
Product Portfolio for PT Kimia Farma
5.9.7. PT Tempo Scan Pacific Tbk
Product Portfolio for PT Tempo Scan Pacific Tbk, Indonesia
5.9.8. PT Merck Tbk
5.9.9. Overview for Other Major Players (Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex) in Indonesia Pharmaceutical Market
5.10. Indonesia Pharmaceutical Market Future Outlook and Projections, 2018-2022
5.10.1. By Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2022
5.10.2. By Generic and Patent Drugs, 2022
5.11. Analyst Recommendations
6. Indonesia Pharmacy Retail Market Introduction
6.1. Indonesia Pharmacy Retail Market Size by Revenue and Number of Pharmacies, 2012-2017
6.2. Indonesia Pharmacy retail Market Segmentation
6.2.1. By Pharmacies and Drugstores, 2012-2017
6.2.2. By Region on the basis of Number of Pharmacies and Drugstores (Central Java, East Java, West Java, North Sumatra, Jakarta and Others), 2015
6.3. Value Chain
Margin Analysis
6.4. Trends and Developments in Pharmacy Retail Market
Indonesia Encouraging Investments from Foreign Companies
Emergence of Science and Technology Parks
Surging imports of Drugs
Increased Life Expectancy and Ageing Population
High Prevalence of Lifestyle- Related Diseases
Growth in Online Retail
6.5. Competition Scenario in Indonesia Pharmacy Retail Market
6.6. Competitive Landscape of Major Organized Pharmacy Chains in Indonesia
6.6.1. Guardian Pharmacy
6.6.2. Kimia Farma
6.6.3. Apotek K-24
6.6.4. A S Watsons group
6.6.5. Other Major players (Century Healthcare)
6.7. Indonesia Pharmacy Retail Market Future Outlook and Projections, 2018-2022
6.7.1. By Pharmacies and Drugstores
6.8. Analyst Recommendation
7. Indonesia Clinical Laboratory Market Introduction
7.1. Indonesia Clinical Laboratory Market Size, 2012-2017
7.2. Indonesia Clinical Laboratory Market Segmentation
7.2.1. By Type of Laboratory (Public Clinical Lab, Private Hospital Labs and Private Independent Labs), 2012-2017
7.2.2. Indonesia Private Independent Laboratory Market Segmentation
By Type of Private Independent Laboratory (Laboratory Chains and Single Independent Laboratory), 2015 & 2016
By Type of Customer (Doctor Referrals, Walk-Ins, Corporate Clients and External Referrals), 2016
By Payer (Private Health Insurance, Corporates, Out of Pocket and BPJS), 2016
By Type of Test (Routine, Non Laboratory and Esoteric), 2016
By Region, 2016
7.3. Value Chain of Clinical Labs Market
7.4. Trends, Developments, Issues and Challenges in Indonesia Clinical Laboratory Market
Universal Health Coverage (UHC) Increases The Demand For Clinical Laboratory Testing
Rising Prevalence of Non-Communicable Diseases (NCDs) and Communicable Diseases (CDs)
Increasing Demand For Health Check-Ups
Introduction of New Specialized Tests
Shortage of Skilled Human Resource Limits Growth
Limitations in Reimbursement per Case Load by BPJS May Limit the Extent of Tests Performed
Failure of Hub-and-Spoke Model
7.5. Government Regulations for Indonesia Clinical Laboratories Market
Classification And Licenses Of Clinical Laboratories
License Application Process
Regulation for Setting up Clinical Laboratory in Indonesia
Regulations on Transport of Tests and Quality Control Management
Regulation for Transporting Samples Abroad
Specimen Collection Point / Hospital Laboratory
Relevant Regulations On The Medical Personnel Law
Foreign Investment Restrictions
7.6. Competition Scenario for Indonesia Clinical Laboratories Market
7.7. Market Share of Major Organized Clinical Laboratories in Indonesia, 2016
7.8. Competitive Landscape of Major Organized Diagnostics Labs in Indonesia
7.8.1. Prodia
7.8.2. Kimia Farma Diagnostika
7.8.3. Pramita
7.8.4. Cito
7.8.5. BioMedika
7.8.6. Parahita
7.9. Indonesia Clinical Laboratory Market Future Outlook and Projections, 2018-2022
7.9.1. By Type of Private Independent Laboratory (Laboratory Chains and Single Independent Laboratory), 2022
7.9.2. By Type of Test (Routine, Non Laboratory and Esoteric), 2022
7.10. Analyst Recommendation
8. Indonesia Medical Device Market Introduction
8.1. Indonesia Medical Devices Market Size, 2012-2017
8.2. Indonesia Medical Devices Market Segmentation
8.2.1. By Type of Medical Devices (Medical consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices and Others), 2014 and 2017
By Type of Medical Consumables (Syringes, Needles, Catheters, Bandages, Dressings, Suturing materials, Ostomy Products and Others), 2014 and 2017
8.2.2. By End Users (Hospitals, Clinics and Others), 2017
8.2.3. By Procurement (Imports and Domestic Production), 2014 and 2017
8.3. Regulatory Environment for Indonesia Medical Devices Market
Classification System for Medical Devices in Indonesia
Document Requirements for Medical Device Registration in Indonesia (MOH RI)
Other Special Requirements
Foreign Medical Devices Registration
Product Certification: SNI ISO 13485:2003
Electronic System to Control Medical Devices
Government Procurement
Import taxes and Duties
STandard Selling Requirement
8.4. Trends, Developments, Issues and Challenges in Indonesia Medical Devices Market
International manufacturers Register in e-catalogue
Rising Demand For More Sophisticated And Modern Medical Products
Challenges In Indonesia Medical Device Market
8.5. Competitive Scenario for Major Players in Indonesia Medical Devices Market
Decision Making Process to Shortlist Medical Device
8.6. Competitive Landscape of Major Players in Indonesia Medical Devices Market
8.6.1. Major Local Manufacturers
8.6.2. Major International Companies
GE Healthcare, Indonesia
Siemens, Indonesia
Philips, Indonesia
8.6.3. Major Local Distributors
PT Mensa Binasukses, Indonesia
PT Transmedic Indonesia
8.6.4. Overview for Other Major Local Distributors (PT Surgika Alkesindo, PT Daya Inti Kurnia Abadi)
8.7. Indonesia Medical Devices Market Future Outlook and Projections, 2018-2022
8.7.1. By Type of Medical Devices (Medical consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices and Others), 2022
8.7.2. By Procurement (Imports and Domestic Production), 2022
9. Indonesia Polyclinic and Health Care Centers Market Snapshot, 2017
Public Health Services
Private Health Services
10. Indonesia Healthcare Industry Market Future Outlook and Projections, 2018-2022
11. Macro Economic Factors Affecting Indonesia Healthcare Market
11.1. Population, 2012-2022
11.2. Number of Primary Health Centers (Puskesmas), 2012-2022
11.3. Budget Allocation on Healthcare, 2012-2022
11.4. Obese Population, 2012-2022
Disclaimer
Contact Us

Figure 1-1: Indonesia Healthcare Market Flowchart, 2017
Figure 3-1: Proportion of New Cases of AIDS on the Basis of Sex, 2016
Figure 3-2: Number of Pneumonia Cases in Indonesia, 2012-2016
Figure 3-3: Prevalence and New Case Detection Rate and Disability Rate of Leprosy per 100,000 Populations in Indonesia, 2011-2016
Figure 3-4: Dengue Hemorrhagic Fever Incidence Rate per 100,000 Populations in Indonesia, 2011-2016
Figure 3-5: Number of Cases of Chikungunya in Indonesia, 2012-2016
Figure 3-6: Cause of Death in Indonesia in Percentage (%), 2015
Figure 3-7: 4 Step Hospital Reimbursement Process under UHC Scheme
Figure 3-8: Indonesia Healthcare Value Chain
Figure 3-9: Indonesia Healthcare Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2012-2017
Figure 3 10: Indonesia Healthcare Market Segmentation by Hospitals, Pharmaceuticals, Medical Devices and Diagnostics on the Basis of Revenues in Percentage (%), 2012-2017
Figure 4-1: Timeline for Major Hospitals in Indonesia
Figure 4-2: Indonesia Hospital Market Size on the Basis of Total Revenue in USD Million and Growth Rate in Percentage (%), 2012-2017
Figure 4-3: Indonesia Hospital Market Size on the Basis of Total Number of Beds, 2012-2016
Figure 4-4: Indonesia Hospital Market Segmentation by Public and Private Hospitals on the Basis of Number of Hospitals in Percentage (%), 2012-2016
Figure 4-5: Indonesia Hospital Market Segmentation by Number of General and Specialty Hospitals in Percentage (%), 2012-2016
Figure 4-6: Indonesia Specialty Hospital Market Segmentation by Specialized Hospitals (Mother and Child Hospital, Maternity Hospital, Mental Hospital, Eye Hospital, Leprosy Hospital, Pulmonary Tuberculosis Hospital and Other Specialized Hospital) on the Basis of Number of Specialty Hospitals in Percentage (%), 2012-2015
Figure 4-7: Indonesia Specialty Hospital Segmentation by Type of Specialized Hospitals (Mother and Child Hospital, Maternity Hospital, Mental Hospital, Eye Hospital, Leprosy Hospital, Pulmonary Tuberculosis Hospital and Other Specialized Hospital) on the Basis of Number of Hospital Beds in Specialty Hospitals in Percentage (%), 2012-2015
Figure 4-8: Multiple Functionalities/ Departments in Indonesia Hospital
Figure 4-9: Indonesia Hospital Business Model based on the Revenue Streams including Inpatient, Outpatient, Diagnostic Labs, Pharmacy and Telemedicine
Figure 4-10: Indonesia Hospitals by Category on the Basis of Number of Hospitals in Percentage (%), 2015
Figure 4-11: Total Revenue in USD Million for Mitra Keluarga Karyasehat Tbk PT, 2012-2016
Figure 4-12: Total Number of Inpatient Days for Mitra Keluarga Karyasehat Tbk PT, 2012-2017
Figure 4-13: Total Number of Outpatient Visits for Mitra Keluarga Karyasehat Tbk PT, 2012-2017
Figure 4-14: Total Number of Operational Beds for Mitra Keluarga Karyasehat Tbk PT, 2012-2016
Figure 4-15: Total Revenue from Inpatients and Outpatients in IDR Billion for Mitra Keluarga Karyasehat Tbk PT, 2012-2017
Figure 4-16: Total Revenue in USD Million for Siloam Hospitals, 2012-2016
Figure 4-17: Total Number of Outpatient Visits for Siloam Hospitals, 2012-2016
Figure 4-18: Total Revenue from Inpatients and Outpatients in IDR Billion for Siloam Hospitals, 2012-2016
Figure 4-19: Total Revenue for PT Sejahteraraya Anugrahjaya in IDR Billion, 2013-2016
Figure 4-20: Total Revenue from Inpatients and Outpatients in IDR Billion for PT Sejahteraraya Anugrahjaya, 2013-2016
Figure 4-21: Total Revenue for Sarana Meditama in IDR Billion, 2012-2017
Figure 4-22: Total Revenue from Rooms (Inpatients) in IDR Billion for Sarana Meditama, 2012-2016
Figure 4-23: Revenues from Outpatient in IDR Billion for Sarana Meditama, 2012-2016
Figure 4-24: Number of Inpatient Admissions in Sarana Meditama, 2012-Q317
Figure 4-25: Average Revenue per Occupied Bed per Day in IDR Million in Sarana Meditama, 2012-Q317
Figure 4-26: Indonesia Hospitals Market Outlook and Future Projections on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2018-2022
Figure 4-27: Outlook and Future Projections for Number of Hospitals in Indonesia, 2018-2022
Figure 4-28: Future Outlook of Number of Hospitals on the Basis of Public Hospitals and Private Hospitals in Indonesia in Percentage (%), 2022
Figure 5-1: Indonesia Pharmaceutical Market Size on the Basis of Revenue in USD Billion and Growth Rate in Percentage (%), 2012-2017
Figure 5-2: Indonesia Pharmaceutical Market Segmentation by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in Percentage (%), 2017
Figure 5-3: Indonesia Vitamin and Dietary Supplements Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2012-2017
Figure 5-4: Indonesia Vitamin and Dietary Supplements Market Segmentation by Distribution Channel on the Basis of Revenue in Percentage (%), 2017
Figure 5-5: Market Share of Major Companies in Indonesia Vitamin and Dietary Supplements Market on the Basis of Revenue in Percentage (%), 2017
Figure 5-6: Indonesia Pharmaceutical Market Segmentation by Domestic and International Players on the Basis of Revenue in Percentage (%), 2012-2017
Figure 5-7: Indonesia Pharmaceutical Market Segmentation by Generic and Patented Drugs on the Basis of Revenue in Percentage (%), 2017
Figure 5-8: Indonesia Generic Drug Market Segmentation by Type (Unbranded, Ethical and Free Sales) on the Basis of Revenue in Percentage (%), 2017
Figure 5-9: Indonesia Pharmaceutical Market Segmentation by OTC and Prescription Drugs on the Basis of Revenue in Percentage (%), 2012-2017
Figure 5-10: Indonesia Pharmaceutical Market Segmentation by Domestic Sales and Exports on the Basis of Revenue in Percentage (%), 2012-2016
Figure 5-11: Indonesia Pharmaceutical Market Segmentation by Region (West Java, East Java, Central Java, Jakarta and Others) on the Basis of Number of Companies in Percentage (%), as of Dec 2016
Figure 5-12: Indonesia Animal Pharmaceutical and Vaccine Market Size on the Basis of Revenue in USD Million, 2012-2017
Figure 5-13: Process of Establishing a Pharmaceutical Company in Indonesia
Figure 5-14: Indonesia Pharmaceutical Market Segmentation on the Basis of Vaccine and Other Pharmaceutical Drugs on the Basis of Revenue in Percentage (%), 2017
Figure 5-15: Indonesia Pharmaceutical Market Share of Major Players on the Basis of Revenue in Percentage (%), 2015
Figure 5-16: Indonesia Pharmaceutical Market Future Projections on the Basis of Revenue in USD Billion, 2018-2022
Figure 5-17: Indonesia Pharmaceutical Market Future Outlook and Projections by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in Percentage (%), 2022
Figure 5-18: Indonesia Pharmaceutical Market Future Projections by Generic and Patent Drugs on the Basis of Revenue in Percentage (%), 2022
Figure 6-1: Indonesia Pharmacy Retail Market Size on the Basis of Revenue in USD Billion and Growth Rate in Percentage (%), 2012-2017
Figure 6-2: Average Revenue of Pharmacies and Drugstores in Indonesia in IDR Billion, 2012-2017
Figure 6-3: Indonesia Pharmacy Retail Segmentation by Pharmacies and Drugstores on the Basis of Revenue in Percentage (%), 2012-2017
Figure 6-4: Number of Pharmacies and Drugstores in Indonesia, 2012-2017
Figure 6-5: Indonesia Pharmacy Retail Market Segmentation by Region (Central Java, East Java, West Java, North Sumatra and Others) by Number of Drugstores in Percentage (%), 2015
Figure 6-6: Value Chain Analysis for Pharmacy Retail Market, Indonesia
Figure 6-7: Pharmaceutical Goods Import in Indonesia in USD Million, 2012-2016
Figure 6-8: Indonesia Pharmacy Retail Market Future Outlook and Projections on the Basis of Revenue in USD Billion, 2017-2022
Figure 6-9: Indonesia Pharmacy Retail Market Future Outlook and Projections by Pharmacies and Drugstores on the Basis of Revenue in Percentage (%), 2017-2022
Figure 6-10: Number of Pharmacies and Drugstores in Indonesia, 2017-2022
Figure 7-1: Indonesia Clinical Laboratory Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2012-2017
Figure 7-2: Indonesia Clinical Laboratory Market Size on the Basis of Number of Tests in Million, 2012-2017
Figure 7-3: Indonesia Clinical Laboratory Market Segmentation by Type of Laboratory (Public Clinical Lab, Private Hospital Labs and Private Independent Labs) on the Basis of Revenue in Percentage (%), 2012-2017
Figure 7-4: Number of Public Clinical Labs, Private Independent Labs and Private Hospital Labs in Indonesia, 2012-2017
Figure 7-5: Indonesia Clinical Laboratory Market Segmentation by Type of Laboratory (Public Hospital Labs, Private Hospital Labs, Private Independent Labs) on the Basis of Number of Tests in Percentage (%), 2012-2017
Figure 7-6: Indonesia Private Independent Laboratory Market Segmentation by Type (Laboratory Chains and Single Independent Laboratory) on the Basis of Revenue in Percentage (%), 2015 & 2016
Figure 7-7: Indonesia Private Independent Laboratory Market Segmentation by Type of Customer (Doctor Referrals, Walk-Ins, Corporate Clients and External Referrals) on the Basis of Number of Tests in Percentage (%), 2016
Figure 7-8: Indonesia Private Independent Laboratory Market Segmentation by Payer (Private Health Insurance, Corporates, Out of Pocket and BPJS) on the Basis of Number of Tests in Percentage (%), 2016
Figure 7-9: Indonesia Private Independent Laboratory Market Segmentation by Type of Test (Routine, Non Laboratory and Esoteric) on the Basis of Revenue in Percentage (%), 2016
Figure 7-10: Indonesia Private Laboratory Market Segmentation by Type of Labs (Private Hospital Labs and Private Independent Labs) in Different Regions on the Basis of Revenue in Percenatge (%), 2016
Figure 7-11: Value Chain for Indonesia Clinical Laboratory Market
Figure 7-12: Process of Applying for License for Clinical Laboratory in Indonesia
Figure 7-13: Market Share of Major Organized Diagnostic Laboratories in Indonesia Private Independent Laboratory Market on the Basis of Revenue in Percentage(%), 2016
Figure 7-14: Market Share of Major Organized Diagnostic Laboratories in Indonesia Private Independent Laboratory Market on the Basis of Number of Private independent Labs in Percentage (%), 2016
Figure 7-15: Indonesia Clinical Laboratory Market Future outlook and Projections on the Basis of Revenue in USD Million, 2018-2022
Figure 7-16: Indonesia Clinical Laboratory Market Future Outlook and Projections on the Basis of Number of Tests in Million, 2018-2022
Figure 7-17: Indonesia Clinical Laboratory Market Future Outlook and Projections by Type of Laboratory (Public Hospital Labs, Private Hospital Labs, Private Independent Labs) on the Basis of Number of Tests/Year in Percentage (%), 2018-2022
Figure 7-18: Indonesia Private Independent Laboratory Market Future Outlook and Projections by Type (Laboratory Chains and Single Independent Laboratory) on the Basis of Revenue in Percentage (%), 2022
Figure 7-19: Indonesia Private Independent Laboratory Market Future Outlook and Projections by Type of Test (Routine, Non Laboratory and Esoteric) on the Basis of Revenue in Percentage (%), 2022
Figure 8-1: Indonesia Medical Device Market Size on the Basis of Revenue in USD Billion and Growth Rate in Percentage (%), 2012-2017
Figure 8-2: Indonesia Medical Devices Market Segmentation by Type of Medical Device (Medical Consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices and Others) on the Basis of Revenue in Percentage (%), 2014 and 2017
Figure 8-3: Indonesia Medical Consumables Market Segmentation by Type (Syringes, Needles, Catheters, Bandages, Dressings, Suturing materials, Ostomy Products and Others) on the Basis of Revenue in Percentage (%), 2014 and 2017
Figure 8-4: Indonesia Medical Devices Market Segmentation by End Users (Hospitals, Clinics and Others) on the Basis of Revenue in Percentage (%), 2017
Figure 8-5: Indonesia Medical Devices Market Segmentation by Procurement (Imports and Domestic Production) on the Basis of Revenue in Percentage (%), 2014 and 2017
Figure 8-6: Indonesia Medical Device Market Future Outlook and Projections on the Basis of Revenue in USD Million, 2018-2022
Figure 8-7: Indonesia Medical Device Market Future Outlook and Projections by Type of Medical Devices (Medical consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices and Others) on the Basis of Revenue in Percentage (%), 2022
Figure 8-8: Indonesia Medical Device Market Future Outlook and Projections by Procurement (Imports and Domestic Production) on the Basis of Revenue in Percentage (%), 2022
Figure 10-1: Indonesia Healthcare Market Future Outlook and Projections on the Basis of Revenue in USD Million, 2018-2022
Figure 10-2: Indonesia Healthcare Market Future Outlook and Projections by Segments (Hospital, Pharmaceutical, Medical Devices and Clinical Laboratory) on the Basis of Revenue in Percentage (%), 2018-2022
Figure 11-1: Population of Indonesia in Million, 2012-2022
Figure 11-2: Number of Primary Health Centers (Puskesmas) in Indonesia, 2012-2022
Figure 11-3: Budget Allocation on Healthcare in Indonesia in IDR Trillion, 2012-2022
Figure 11-4: Obese Population in Indonesia in Million, 2012-2022

Table 2-1: Therapeutic Segments Covered in Indonesia Pharmaceutical Market
Table 2-2: Type of Medical Devices in Indonesia Medical Device Market
Table 2-3: Type of Radiology Tests in Indonesia Non Laboratory Tests Market
Table 2-4: Correlation Matrix for Indonesia Healthcare Market
Table 2-5: Regression Coefficients Output
Table 3-1: Indonesia Healthcare Statistics on the basis of Healthcare Parameters
Table 3-2: Comparison of Indonesia Healthcare Statistics with Vietnam, Malaysia, Singapore, South Korea, India, China and Australia, 2016
Table 3-3: Major Cause of Death or Disability in Indonesia per 100,000 Populations, 2016
Table 3-4: Indonesia Tuberculosis Profile on the basis of Healthcare Parameters, 2016
Table 3-5: Estimated TB Incidence in Indonesia by Age and Sex in Thousands 2016
Table 3-6: Number of New cases of HIV Positive and AIDS, Indonesia, 2011-2016
Table 3-7: Diarrhea Outbreaks in Indonesia, 2011-2015
Table 3-8: Incidence of Malaria per 1,000 populations Indonesia, 2011-2016
Table 3-9: Facts of Indonesia’s UHC/JKN (Jaminan Kesehatan Nasional)
Table 3-10: Indonesia Healthcare Insurance including Public Health Insurance Overview and Private Health Insurance Overview
Table 3-11: Indonesia’s Universal Health Coverage Scheme and Private Insurance
Table 3-12: Entities and Description for Indonesia Healthcare Value Chain
Table 3-13: Cross Comparison of Major Entities Involved in Indonesia Hospital Sector, 2016
Table 3-14: SWOT Analysis of Indonesia Healthcare Market
Table 3-15: Key Developments in Indonesia Healthcare Market, 2012-2017
Table 3-16: Change in Foreign Investment Regulation in Different Healthcare Verticals in Indonesia
Table 3-17: Indonesia Healthcare Market Segmentation by Hospitals, Pharmaceuticals, Medical Devices and Clinical Laboratory on the Basis of Revenues in USD Million, 2012-2017
Table 3-18: Key Developments in Indonesia Healthcare Market Segmentation by Hospitals, Pharmaceuticals, Medical Devices and Diagnostics, 2012-2017
Table 4-1: Key Developments in Indonesia Hospital Market, 2012-2017
Table 4-2: Hospital Cost in Jakarta, Indonesia
Table 4-3: Key Takeaways in Indonesia Hospital Market Segmentation by Number of Public and Private Hospitals, 2012-2016
Table 4-4: Indonesia Hospital Market Segmentation by Number of Public and Private Hospitals, 2012-2016
Table 4-5: Number of Hospitals in Indonesia by Ownership as of YTD September 2017
Table 4-6: Key Takeaway on Indonesia Hospital Market Segmentation by Number of General and Specialty Hospitals, 2012-2016
Table 4-7: Indonesia Hospital Market Segmentation by Number of General and Specialty Hospitals, 2012-2016
Table 4-8: Key Takeaway on Indonesia Specialty Hospital Market Segmentation by Type of Specialty Hospitals (Mother and Child Care Hospital, Maternity Hospital, Mental Hospital, Eye Hospital, Leprosy Hospital, Pulmonary Tuberculosis Hospital and Other Specialized Hospital), 2012-2015
Table 4-9: Indonesia Specialty Hospitals Segmentation by Type of Specialized Hospitals (Mother and Child Hospital, Maternity Hospital, Mental Hospital, Eye Hospital, Leprosy Hospital, Pulmonary Tuberculosis Hospital and Other Specialized Hospital) on the Basis of Number of Specialty Hospitals in Units, 2012-2015
Table 4-10: Indonesia Specialty Hospitals Market Segmentation by Type of Specialty Hospital (Mother and Child Hospital, Maternity Hospital, Mental Hospital, Eye Hospital, Leprosy Hospital, Pulmonary Tuberculosis Hospital and Other Specialized Hospital) on the Basis of Hospital Beds in Specialty Hospital Units, 2012-2015
Table 4-11: Indonesia Hospital Market Segmentation by Region (East Java, Central java, West Java, DKI Jakarta, North Sumatra, South Sulawesi, Banten and Others) on the Basis of Number of Beds, 2016
Table 4-12: Indonesia Hospitals Market Segmentation by Region on the Basis of Hospital Beds in Units and Percentage (%), 2016
Table 4-13: Healthcare Facilities in West Java by Various Regencies as of 2012
Table 4-14: Average Length of Stay for Inpatient, Average Inpatient Bill and Average OPD Consultation Charges, 2016
Table 4-15: Indonesia Hospitals (Siloam Hospitals and Mitra Keluarga Karyasehat Tbk PT) Details in Terms of Number of Admissions Inpatient, Number of Admissions Outpatient, Total Patient, Bed Occupancy Ratio, IPD Average Revenue Per Patient and OPD Average Revenue Per Patient, 2015-2016
Table 4-16: Government Initiatives, Rules and Regulations in Indonesia Hospital Market
Table 4-17: Regulations and Implications for Non-Indonesian Stakeholders
Table 4-18: Major Hospital Projects in Indonesia Hospital Market on the Basis of Name of Hospital, Year of Construction and Description
Table 4-19: Competitive Analysis of Major Hospital Players including Private Hospital Groups, No. of Hospitals, No. of Hospitals in Greater Jakarta Area, No. of Hospitals Outside Greater Jakarta Area, No. of Beds and Specialty, 2017
Table 4-20: Classification of Indonesian Hospitals
Table 4-21: Indonesia Hospitals by Category on the Basis of Number of Hospitals, 2015
Table 4-22: Competitive Landscape for Mitra Keluarga Karyasehat Tbk Pt on the Basis of Hospital Overview, Business Strategies, Locations, Employee Base, Medical Services Available, Number of Operational Beds and Key Personnel
Table 4-23: Number of Operational Beds in Mitra Keluarga Karyasehat Tbk PT on the Basis of Hospital, 2016
Table 4-24: Competitive Landscape for Siloam Hospitals on the Basis of Hospital Overview, Business Strategies, Number of Employees, Medical Services Available, Bed Occupancy Rate, Emergency Visits and Number of Inpatient Visits
Table 4-25: Pricing Comparison of Inpatient Ward Charges for Siloam Hospital with RS MH Thamrin, RS Bhakti Husada and RSUD Bayu Asih (IDR per overnight stay)
Table 4-26: Key Stats for Siloam Hospitals, 2012-2016
Table 4-27: Inpatient Revenue Break-up for Siloam Hospitals in IDR Billion, 2012-2016
Table 4-28: Outpatient Revenue Break-up for Siloam Hospitals in IDR Billion, 2012-2016
Table 4-29: Siloam Hospitals on the Basis of Bed Capacity, operational Beds, GP and Specialist, Nurses, Specialty and Location, YTD September 2017
Table 4-30: SWOT Analysis for Siloam Hospitals Located in Purwakarta, Java
Table 4-31: Patient Profile in Primary Catchment Area within 15 km Radius of Siloam Hospitals Located in Purwakarta, Java
Table 4-32: Patient Profile in the Catchment Area beyond 15 km Radius of Siloam Hospitals Located in Purwakarta, Java
Table 4-33: Competitive Landscape for PT Sejahteraraya Anugrahjaya on the Basis of Hospital Overview, Business Strategies, Medical Services Available, Total Beds, Average Revenue Per Bed, Employee Base and Key Personnel
Table 4-34: Revenue of PT Sejahteraraya Anugrahjaya from Medicines, In-patients, Polyclinics, Laboratory, Radiology, Medical Check-up and Hemodialysis in IDR Million, 2015-2016
Table 4-35: Competitive Landscape for Sarana Meditama on the Basis of Hospital Overview, Business Strategies, Service Portfolio, Employee Base, Medical Experts, Number of Beds, Income Per Outpatient, Income per Inpatient, Average Revenue Per Bed and Key Personnel
Table 4-36: Description of Major Omni Hospitals
Table 4-37: Overview of Omni Hospital Facilities, YTD September 2017
Table 4-38: Competitive Landscape for Rumah Sakit Pondok Indah on the Basis of Hospital Overview, Facilities, Business Strategies and Service Portfolio
Table 4-39: Competitive Landscape for Surya Husadha General Hospital on the Basis of Hospital Overview, Service Portfolio, Employee Base and Medical Experts
Table 4-40: Competitive Landscape for Jakarta Eye Center on the Basis of Hospital Overview, USP, Business Strategies, Service Portfolio, Number of Hospitals, Facilities and Professional Physicians and Practitioners
Table 4-41: Other Indonesian Hospital Profiles including Rumah Sakit Dr Oen Surakarta, Pertamedika (Rumah Sakit Pusat Pertamina), Kaish Ibu Hospital, Hermina Hospital Group, Awal Bros Hospital Group and Sari Asih
Table 4-42: Future Drivers for Indonesia Hospitals Market
Table 4-43: Upcoming Hospital Projects in Indonesia
Table 4-44: Analyst Recommendation for Indonesia Hospital Market
Table 5-1: Introduction for Indonesia Pharmaceutical Industry
Table 5-2: Key Developments in Indonesia Pharmaceutical Market, 2012-2017
Table 5-3: Indonesia Pharmaceutical Market Segmentation by Therapeutic Segments (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in USD Million, 2015 and 2017
Table 5-4: Indonesia Pharmaceutical Market Segmentation by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Best Selling Medicines, major Companies and OTC and Prescribed
Table 5-5: Indonesia Vitamin and Dietary Supplements Market Segmentation by Distribution Channel on the Basis of Revenue in USD Million, 2017
Table 5-6: Market Share of Major Companies in Indonesia Vitamin and Dietary Supplements Market on the Basis of Revenue in USD Million, 2012-2017
Table 5-7: Indonesia Pharmaceutical Market Segmentation by Domestic and International Players on the Basis of Revenue in USD Billion, 2012-2017
Table 5-8: Key Takeaways for Indonesia Pharmaceutical Market Segmentation by Domestic and International Players
Table 5-9: Major Therapeutic Segments for Domestic and International Companies
Table 5-10: Indonesia Pharmaceutical Market Segmentation by Generic and Patented Drugs on the Basis of Revenue in USD Billion, 2017
Table 5-11: Indonesia Pharmaceutical Market Segmentation by Generic and Patented Drugs on the Basis of Best Selling Medicines, Major Companies and Therapeutic Class
Table 5-12: Indonesia Generic Drug Market Segmentation by Type (Unbranded, Ethical and Free Sales) on the Basis of Revenue in USD Billion, 2013 and 2017
Table 5-13: Indonesia Pharmaceutical Market Segmentation by OTC and Prescription Drugs on the Basis of Revenue in USD Billion, 2012-2017
Table 5-14: Indonesia Pharmaceutical Market Segmentation by Domestic Sales and Exports on the Basis of Revenue in USD Million, 2012-2016
Table 5-15: Indonesia Pharmaceutical Products Export by Value in USD Thousand, 2014-2016
Table 5-16: Indonesia Pharmaceutical Market Segmentation by Region (West Java, East Java, Central Java, Jakarta and Others) on the Basis of Number of Companies, as of Dec 2016
Table 5-17: Major Mergers, Acquisitions and Joint Ventures in Indonesia Pharmaceutical Industry during 2012-2017
Table 5-18: Major Alliances in Indonesia Pharmaceutical Industry
Table 5-19: Registration of Finished Pharmaceutical Products in Indonesia
Table 5-20: Procedure for Applying for Patent in Indonesia.
Table 5-21: Snapshot for Indonesia Biopharmaceutical Industry
Table 5-22: Competitive Landscape of Innogene Kalbiotech including Overview, Products and Services, Partners and Business Strategies
Table 5-23: Indonesia Pharmaceutical Market Segmentation on the Basis of Vaccine and Other Pharmaceutical Drugs on the Basis of Revenue in USD Billion, 2017
Table 5-24: Competitive Parameters in Indonesia Pharmaceutical Market
Table 5-25: Rationale for Market Share of Major Players in Indonesia Pharmaceutical Market, 2015
Table 5-26: Market Share of Major Players in Indonesia Pharmaceutical Market on the Basis of Revenue in USD Million, 2015
Table 5-27: Competitive Landscape of PT Kalbe Farma including Company Overview, USP, Business Segments, Corporate Social Responsibility, Certifications and Accreditations, Manufacturing Plants, Business Strategies, Number of Employees, Best Selling products, New Product Launches and Recent Developments
Table 5-28: Market Share of Major Products of PT Kalbe Farma on the Basis of Volume in Percentage (%), 2016
Table 5-29: Manufacturing Facility of PT Kalbe Farma
Table 5-30: Product Portfolio for PT Kalbe Farma, Indonesia
Table 5-31: Competitive Landscape of PT Sanbe Farma including Company Overview, USP, Product Segments, Subsidiaries, Certifications and Accreditations, Plants, Future Strategies, Number of Employees and Distribution Network
Table 5-32: Product portfolio for PT Sanbe Farma, Indonesia
Table 5-33: Competitive Landscape of PT SOHO Global Health including Company Overview, USP, Product Segments, Subsidiaries, Certifications and Accreditations, Plants, Future Strategies, Number of Employees and Distribution Network
Table 5-34: Competitive Landscape of PT Dexa Medica including Company Overview, USP, Product Segments, Business Strategies, Estimate Revenue and Number of Employees
Table 5-35: Major Products Portfolio for PT Dexa Medica, Indonesia
Table 5-36: Competitive Landscape of PT Pharos including Company Overview, USP, Product Segments, Business Strategies and Number of Employees
Table 5-37: Product Portfolio for PT Pharos, Indonesia
Table 5-38: Competitive Landscape of PT Kimia Farma including Company Overview, Strength, Product Segments, Business Strategies and Number of Employees
Table 5-39: Type of Products Manufactured at Different Manufacturing Facilities of Kimia Farma, Indonesia
Table 5-40: Major Products Portfolio for PT Kimia Farma, Indonesia
Table 5-41: Competitive Landscape of PT Tempo Scan Pacific Tbk including Company Overview, USP, Product Line, Business Division, Distribution Network, Corporate Social Responsibility, Business Strategies and Number of Employees
Table 5-42: Manufacturing Facility for PT Tempo Scan Pacific Tbk, Indonesia
Table 5-43: Product Portfolio for PT Tempo Scan Pacific Tbk, Indonesia
Table 5-44: Competitive Landscape for PT Merck Tbk including Company Overview, Business Segments, Key Stats, Best Selling products and Business Strategy
Table 5-45: Key products in Biopharma Division for Merck Indonesia on the Basis of Therapeutic Segment
Table 5-46: Key products in Consumer Health Division for Merck Indonesia on the Basis of Therapeutic Segment
Table 5-47: Overview of Major Players (Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex) in Indonesia Pharmaceutical Market
Table 5-48: Indonesia Pharmaceutical Market Future Outlook and Projections, 2018-2022
Table 5-49: Indonesia Pharmaceutical Market Future Outlook and Projections by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in USD Billion, 2022
Table 5-50: Indonesia Pharmaceutical Market Future Outlook and Projections by Generic and Patent Drugs on the Basis of Revenue in USD Billion, 2022
Table 5-51: Analyst Recommendation for Indonesia Pharmaceutical Market
Table 6-1: Indonesia Pharmacy Retail Market Size on the Basis of Revenue in USD Billion, 2012-2017
Table 6-2: Indonesia Pharmacy Retail Segmentation by Pharmacies and Drugstores on the Basis of Revenue in IDR Billion, 2012-2017
Table 6-3: Indonesia Pharmacy Retail Segmentation by Pharmacies and Drugstores on the Basis of Number of Stores, 2012-2017
Table 6-4: Indonesia Pharmacy Retail Segmentation by Sales Channel (Independent Pharmacies, Independent Drugstores and Hospitals, Clinics and Doctors) on the Basis of Revenue in IDR Billion, 2017
Table 6-5: Rationale for Indonesia Pharmacy Retail Segmentation by Pharmacies and Drugstores
Table 6-6: Indonesia Pharmacy Retail Market Segmentation by Region (Central Java, East Java, West Java, North Sumatra, Jakarta and Others) by Number of Pharmacies and Drugstores as of December 2015
Table 6-7: Number of Pharmaceutical Manufacturers, Exporters, Wholesalers, Pharmacies, Drugstores, Clinics, Doctors and Hospitals in Indonesia
Table 6-8: Major Competition Parameters in Indonesia Pharmacy Retail Market
Table 6-9: Competitive Landscape of Guardian Pharmacy including Company Overview, USP, Product Segments and Number of Stores
Table 6-10: Competitive Landscape of Kimia Farma including Company Overview, Number of Branches, Number of Employees, Business Strategy, Key Stats, and Product Categories
Table 6-11: Competitive Landscape of Apotek K-24 including Company Overview, USP, Number of Pharmacies, Estimated Revenue, Product Categories and Services Offered
Table 6-12: Competitive Landscape of A S Watsons Group including Company Overview, USP, Number of Pharmacies, Estimated Revenue, Product Categories and Services Offered
Table 6-13: Overview of Other Major Players (Century Healthcare) in Indonesia Pharmacy Retail Market
Table 6-14: Future Outlook and Drivers for Indonesia Pharmacy Retail Market, 2018-2022
Table 6-15: Indonesia Pharmacy Retail Market Future Outlook and Projections by Pharmacies and Drugstores on the Basis of Revenue in IDR Billion, 2017-2022
Table 6-16: Analyst Recommendation for Indonesia Pharmacy Retail Market
Table 7-1: Introduction for Indonesia Clinical Laboratory Industry
Table 7-2: Indonesia Clinical Laboratory Market Size on the Basis of Revenue in USD Million, 2012-2017
Table 7-3: Indonesia Clinical Laboratory Market Segmentation by Type of Laboratory (Public Clinical Lab, Private Hospital Labs and Private Independent Labs) on the Basis of Revenue in USD Million, 2012-2017
Table 7-4: Indonesia Clinical Laboratory Market Segmentation by Type of Laboratory (Public Hospital Labs, Private Hospital Labs, Private Independent Labs) on the Basis of Number of Tests in Million, 2012-2017
Table 7-5: Indonesia Private Independent Laboratory Market Segmentation by Type (Laboratory Chains and Single Independent Laboratory) on the Basis of Revenue in USD Million, 2015 and 2016
Table 7-6: Indonesia Private Independent Laboratory Market Segmentation by Type of Customer (Doctor Referrals, Walk-Ins, Corporate Clients and External Referrals) on the Basis of Number of Tests, 2016
Table 7-7: Rationale for Indonesia Private Independent Laboratory Market Segmentation by Type of Customer (Doctor Referrals, Walk-Ins, Corporate Clients and External Referrals), 2016
Table 7-8: Rationale for Indonesia Private Independent Laboratory Market Segmentation by Payer (Private Health Insurance, Corporates, Out of Pocket and BPJS), 2016
Table 7-9: Indonesia Private Independent Laboratory Market Segmentation by Type of Test (Routine, Non Laboratory and Esoteric) on the Basis of Revenue in USD Million, 2016
Table 7-10: Indonesia Clinical Laboratory Market Segmentation by Type of Test (Routine, Non Laboratory and Esoteric) on the Basis of Best Selling Medicines, Major Labs and Price
Table 7-11: Indonesia Private Laboratory Market Segmentation by Type of Labs (Private Hospital Labs and Private Independent Labs) in Different Regions on the Basis of Revenue in USD Million, 2016
Table 7-12: Indonesia Private Independent Lab Collaboration with BPJS
Table 7-13: Clinical Laboratories Classification and Minimum Requirement for Medical Personnel in Indonesia Clinical Laboratory Market
Table 7-14: Regulations for Setting up a Clinical Laboratory in Indonesia
Table 7-15: Regulations on Transport of Tests and Quality Control Management, Indonesia
Table 7-16: Regulation for Transporting Samples Abroad, Indonesia
Table 7-17: Minimum Human Resource Requirement on the Basis of Type of Clinical Laboratory, Indonesia
Table 7-18: List of Foreign Investment Restrictions in Indonesia Clinical Laboratory Market
Table 7-19: Major Competition Parameters in Indonesia Clinical Laboratory market
Table 7-20: Market Share of Major Organized Diagnostic Laboratories in Indonesia Private Independent Laboratory Market on the Basis of Revenue in USD Million, 2016
Table 7-21: Strengths and Weakness for Major Organized Clinical Laboratories in Indonesia
Table 7-22: Market Share of Major Organized Clinical Laboratories in Indonesia Private Independent Laboratory Market on the Basis of Number of Private Independent Labs, 2016
Table 7-23: Competitive Landscape of Prodia including Company Overview, Key Developments, Number of Branches, Strengths, Key Stats, Products and Services, Research and Developments and Business Strategy
Table 7-24: Description of Various Facility and Services offered by Prodia
Table 7-25: Prodia Merger, Acquisition, and Partnership Assessment, Indonesia, 2012-2015
Table 7-26: Comprehensive Service Portfolio for Prodia
Table 7-27: Key Statistics for Prodia, 2013-2017
Table 7-28: Region Wise Lab Distribution of Prodia, YTD September 2017
Table 7-29: Prodia Revenue Split by Region in IDR Billion, 2013-2016
Table 7-30: Number of Clinical Laboratory, PHC Clinic, Specialty Clinic, POC Services and Hospital laboratory for Prodia, 2012-YTD September 2017
Table 7-31: Number of Patient Visit Segmentation by Customer Type (Walk-in, Doctor Referral, External Referral, Corporate Clients and Prodia Specialty Labs), 2013-2016
Table 7-32: Prodia Revenue Split by Type of Customer (Walk-in, Doctor Referral, External Referral, Corporate Clients and Prodia Specialty Labs) in IDR Billion, 2013-2016
Table 7-33: Competitive Landscape of Kimia Farma Diagnostika including Company Overview, Services, number of Branches and Business Strategy
Table 7-34: Competitive Landscape of Pramita including Company Overview, Services, number of Branches and Business Strategy
Table 7-35: Service Portfolio for Cito, Indonesia
Table 7-36: Competitive Landscape of BioMedika including Company Overview, Products and Service and Key Developments
Table 7-37: Competitive Landscape of Parahita, Indonesia including Company Overview, Services, Key Developments and Number of Branches
Table 7-38: Indonesia Clinical Laboratory Market Future outlook and Projections on the Basis of Revenue in USD Million, 2018-2022
Table 7-39: Indonesia Clinical Laboratory Market Future Outlook and Projections by Type of Laboratory (Public Hospital Labs, Private Hospital Labs, Private Independent Labs) on the Basis of Number of Tests in Million, 2018-2022
Table 7-40: Indonesia Private Independent Laboratory Market Future Outlook and Projections by Type (Laboratory Chains and Single Independent Laboratory) on the Basis of Revenue in USD Million, 2022
Table 7-41: Indonesia Private Independent Laboratory Market Future Outlook and Projections by Type (Laboratory Chains and Single Independent Laboratory), 2022
Table 7-42: Indonesia Private Independent Laboratory Market Future Outlook and Projections by Type of Test (Routine, Non Laboratory and Esoteric) on the Basis of Revenue in USD Million, 2022
Table 7-43: Future Outlook and Drivers for Indonesia Private Independent Laboratory Market by Type of Test (Routine, Non Laboratory and Esoteric), 2022
Table 7-44: Analyst Recommendation for Indonesia Clinical Laboratory Market
Table 8-1: Introduction for Indonesia Medical Device Industry
Table 8-2: Indonesia Medical Devices Market Size and Description on the Basis of Revenues, 2012-2017
Table 8-3: Indonesia Medical Devices Market Segmentation by Type of Medical Device (Medical consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices and Others) on the Basis of Revenue in USD Million, 2014 and 2017
Table 8-4: Application of Major Diagnostic Imaging Products
Table 8-5: Indonesia Medical Devices Market Segmentation by Type of Medical Device (Medical consumable Products, Diagnostic Imaging Products, Aesthetic Devices) on the Basis of Best Selling Medical Device, Major Companies and Major End Users and Average Prices
Table 8-6: Indonesia Medical Consumables Market Segmentation by Type (Syringes, Needles, Catheters, Bandages, Dressings, Suturing materials, Ostomy Products and Others) on the Basis of Revenue in USD Million, 2014 and 2017
Table 8-7: Indonesia Medical Devices Market Segmentation by End Users (Hospitals, Clinics and Others) on the Basis of Revenue in USD Million, 2017
Table 8-8: Indonesia Medical Devices Market Segmentation by Procurement (Imports and Domestic Production) on the Basis of Revenue in USD Million, 2014 and 2017
Table 8-9: Regulation of Medical Devices in Indonesia by MOH RI
Table 8-10: Classification System for Medical Devices in Indonesia
Table 8-11: Special Requirements for Distribution of Medical Devices in Indonesia
Table 8-12: Steps to Register Medical Devices in Indonesia
Table 8-13: Indonesia Medical Device Regulation System
Table 8-14: Major Medical Device Distributors in Indonesia and their Principal Brands
Table 8-15: Major Competing Parameters in Indonesia Medical Device Market
Table 8-16: Decision Making Process to Shortlist Medical Device with Parameters and Weightage in Percentage (%)
Table 8-17: Company Overview for Major Local Manufacturers (PT Trimitra Garmedindo Interbuana, Citra Medika Lestari (CML), PT Andini Sarana, Indo Health Medical, PT Mega Andalan Kalasan) in Indonesia Medical Device Market
Table 8-18: Product Portfolio for PT Trimitra Garmedindo Interbuana, Indonesia
Table 8-19: Product Portfolio for Citra Medika Lestari, Indonesia
Table 8-20: Product Portfolio for PT Andini Sarana, Indonesia
Table 8-21: Competitive Landscape of GE Healthcare, Indonesia including Company Overview, Services Offered, Business Strategy and Specialties
Table 8-22: Competitive Landscape of Siemens, Indonesia including Company Overview, Business Divisions, Number of Employees and Products and Services
Table 8-23: Competitive Landscape of Philips, Indonesia including Company Overview, Business Lines, Product Lines and Specialties
Table 8-24: Company Overview for other Major International Companies (Samsung Indonesia and Hitachi Indonesia) in Indonesia Medical Devices Market
Table 8-25: Competitive Landscape of PT Mensa Binasukses, Indonesia including Company Overview, Logistics, IT Systems, Number of Clients, Number of Employees and Coverage
Table 8-26: Distribution Network for PT Mensa Binasukses, Indonesia
Table 8-27: Competitive Landscape of PT Transmedic, Indonesia including Company Overview, Latest Products, Major Brands and Number of Employees
Table 8-28: Company Overview for other Major Local Distributors (PT Surgika Alkesindo, PT Daya Inti Kurnia Abadi) in Indonesia Medical Devices Market
Table 8-29: Future Drivers for Indonesia Medical Devices Market
Table 8-30: List of Medical Devices not produced in Indonesia
Table 8-31: Indonesia Medical Device Market Future Outlook and Projections by Type of Medical Devices (Medical consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices and Others) on the Basis of Revenue in USD Million, 2022
Table 8-32: Indonesia Medical Device Market Future Outlook and Projections by Procurement (Imports and Domestic Production) on the Basis of Revenue in USD Million, 2022
Table 9-1: Number of Inpatient, Outpatient and total Puskesmas in Indonesia, 2012-2017
Table 10-1: Future Drivers for Indonesia Healthcare Market
Table 10-2: Indonesia Healthcare Market Future Outlook and Projections by Segments (Hospital, Pharmaceutical, Medical Devices and Clinical Laboratory) on the Basis of Revenue in USD Million, 2018-2022
Table 11-1: Key Developments in Population of Indonesia, 2012-2022
Table 11-2: Key Developments in Number of Primary Health Centers (Puskesmas) in Indonesia, 2012-2022
Table 11-3: Key Developments in Budget Allocation on Healthcare in Indonesia, 2012-2022
Table 11-4: Key Developments in Obese Population in Indonesia, 2012-2022

Single User License:
Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

Hard Copy License:
The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

Corporate User License:
Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Hospitals (Mitra Keluarga Karyasehat Tbk Pt, Siloam Hospitals, PT Sejahteraraya Anugrahjaya, Sarana Meditama, Rumah Sakit Pondok Indah, Surya Husadha, Jakarta Eye Center), pharmaceutical companies (PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific, PT Merck), Pharmacy Retail (Guardian Pharmacy, Kimia Farma, Apotek K-24, A S Watsons, Century Healthcare), Diagnostic Laboratories (Prodia, Kimia Farma Diagnostika, Pramita, Cito, BioMedika, Parahita), Medical Devices Companies (GE Healthcare Indonesia, Siemens Indonesia, Philips Indonesia, PT Mensa Binasukses, PT Transmedic Indonesia)

Healthcare, hospitals, Pharmaceuticals, Medical Devices, Clinical Laboratory; Hospital market (by public & private hospitals, by general & specialty hospitals and by region), pharmaceutical market (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), pharmacy retail market (by pharmacies & drugstores and by region), clinical laboratory market (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region), Medical Device market (by type of medical device, by type of medical consumables, by end user and by procurement)

select a license

Single User License
USD 4500 INR 323460
Hard Copy License
USD 6000 INR 431280
Corporate User License
USD 8000 INR 575040

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com